Brittany Dashevsky, MD
Diagnostic Radiology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Dashevsky’s office at (650) 723-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A148784 · Current
Licensed to practise in California · since 2017 · expires 2028-08-31 · Albert Einstein College of Medicine of Yeshiva University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$113,183
Medicare paid this office $113,183 for 1,420 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Screening mammography | 576 | $23,273 | $40 |
| Screening 3d breast mammography | 576 | $18,278 | $32 |
| Screening mammography | 314 | $12,692 | $40 |
| Screening 3d breast mammography | 314 | $9,984 | $32 |
| Mri scan of both breasts | 79 | $7,124 | $90 |
See all 23 services
| Screening mammography | 576 | $23,273 | $40 |
| Screening 3d breast mammography | 576 | $18,278 | $32 |
| Screening mammography | 314 | $12,692 | $40 |
| Screening 3d breast mammography | 314 | $9,984 | $32 |
| Mri scan of both breasts | 79 | $7,124 | $90 |
| Mri scan of both breasts | 75 | $6,761 | $90 |
| Diagnostic mammography of both breasts | 88 | $3,092 | $35 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 124 | $2,689 | $22 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 18 | $2,417 | $134 |
| Diagnostic mammography of 1 breast | 73 | $2,353 | $31 |
| Limited ultrasound scan of 1 breast | 76 | $1,997 | $26 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 14 | $1,875 | $134 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | 14 | $1,846 | $132 |
| Complete ultrasound scan of 1 breast | 45 | $1,758 | $39 |
| Diagnostic mammography of 1 breast | 48 | $1,626 | $33 |
| Diagnostic mammography of both breasts | 38 | $1,600 | $41 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 60 | $1,501 | $25 |
| Complete ultrasound scan of 1 breast | 31 | $1,408 | $45 |
| Limited ultrasound scan of 1 breast | 48 | $1,372 | $29 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 15 | $498 | $29 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 14 | $440 | $27 |
| X-ray of surgical specimen | 22 | $301 | $13 |
| X-ray of surgical specimen | 16 | $245 | $14 |
Who their Medicare patients are
1,420 Original Medicare patients in 2024. Average age 73 · Under 65 5% · 85 and older 6% · Also on Medicaid 14% · Health risk score 0.93. At or below the middle of the specialty; the typical diagnostic radiology clinician is at 1.7.
Conditions among them: High blood pressure 53% · Cancer 42% · Diabetes 19% · Coronary heart disease 15% · Depression 14% · Chronic kidney disease 11% · Atrial fibrillation 9% · Heart failure 7% · COPD 6% · Stroke 5% · Dementia 2%.
The office billed $1,183,105, Medicare allowed $130,062 and paid $113,183; for 2,792 services of 26 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,420 | 2,792 | 73 | 0.93 | $1,183,105 | $113,183 |
| 2023 | 1,351 | 2,761 | 72 | 0.89 | $867,902 | $114,149 |
| 2022 | 2,307 | 4,194 | 74 | 1.22 | $244,701 | $129,292 |
| 2021 | 2,942 | 5,447 | 74 | 1.30 | $295,803 | $175,697 |
| 2020 | 2,738 | 5,001 | 74 | 1.56 | $332,876 | $162,626 |
| 2019 | 2,741 | 4,908 | 74 | 1.50 | $366,073 | $161,291 |
| 2018 | 1,927 | 3,314 | 73 | 1.47 | $211,928 | $100,668 |
| 2017 | 53 | 59 | 69 | 3.18 | $16,195 | $478 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Screening mammography | 637 | $26,971 | $42 |
| Screening 3d breast mammography | 637 | $21,333 | $33 |
| Screening mammography | 238 | $10,077 | $42 |
| Mri scan of both breasts | 87 | $8,126 | $93 |
| Screening 3d breast mammography | 238 | $7,971 | $33 |
| Mri scan of both breasts | 61 | $5,452 | $89 |
| Diagnostic mammography of both breasts | 111 | $4,585 | $41 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 172 | $4,295 | $25 |
| Diagnostic mammography of 1 breast | 92 | $3,099 | $33 |
| Limited ultrasound scan of 1 breast | 93 | $3,016 | $31 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 15 | $2,015 | $134 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | 12 | $1,727 | $144 |
| Diagnostic mammography of both breasts | 39 | $1,650 | $42 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 66 | $1,590 | $24 |
| Complete ultrasound scan of 1 breast | 30 | $1,377 | $46 |
| Diagnostic mammography of 1 breast | 43 | $1,322 | $31 |
| Limited ultrasound scan of 1 breast | 38 | $1,087 | $29 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 24 | $789 | $28 |
| X-ray of surgical specimen | 17 | $239 | $14 |
2022: 27 services
| Screening mammography | 1,174 | $45,371 | $39 |
| Screening 3d breast mammography | 1,184 | $37,208 | $31 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 37 | $4,156 | $109 |
| X-ray of chest, 1 view | 460 | $3,801 | $7 |
| Diagnostic mammography of 1 breast | 111 | $3,570 | $30 |
| Mri scan of both breasts | 36 | $3,252 | $88 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 129 | $2,992 | $23 |
| Limited ultrasound scan of 1 breast | 104 | $2,845 | $27 |
| Ct scan of abdomen and pelvis without contrast | 39 | $2,763 | $71 |
| Ct scan of abdomen and pelvis with contrast | 31 | $2,412 | $75 |
| Diagnostic mammography of both breasts | 60 | $2,391 | $40 |
| Ct scan head or brain without contrast | 76 | $2,358 | $30 |
| Ct scan of chest with contrast | 24 | $1,103 | $46 |
| Ct scan of upper spine without contrast | 26 | $1,056 | $41 |
| Dxa bone density measurement of hip, pelvis, spine | 98 | $1,009 | $10 |
| Placement of locating device in breast using imaging guidance, first growth | 12 | $942 | $79 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 33 | $854 | $26 |
| Ct scan of chest without contrast | 17 | $699 | $41 |
| X-ray of chest, 2 views | 62 | $480 | $8 |
| Complete ultrasound scan behind abdominal cavity | 13 | $393 | $30 |
| Injection of radioactive material for x-ray identification of lymph node | 16 | $347 | $22 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 19 | $309 | $16 |
| Limited ultrasound scan of abdomen | 12 | $266 | $22 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 16 | $253 | $15 |
| Dxa bone density measurement of forearm, finger, hand, or foot | 22 | $233 | $11 |
| X-ray of abdomen, 1 view | 24 | $183 | $8 |
| X-ray of knee, 3 views | 12 | $111 | $8 |
2021: 34 services
| Screening mammography | 1,527 | $59,651 | $39 |
| Screening 3d breast mammography | 1,528 | $48,208 | $32 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 46 | $6,126 | $125 |
| Ct scan of abdomen and pelvis with contrast | 71 | $5,224 | $74 |
| X-ray of chest, 1 view | 613 | $4,933 | $7 |
| Diagnostic mammography of 1 breast | 133 | $4,740 | $31 |
| Ct scan head or brain without contrast | 136 | $4,632 | $33 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 153 | $3,519 | $23 |
| Limited ultrasound scan of 1 breast | 121 | $3,439 | $25 |
| Ct scan of abdomen and pelvis without contrast | 43 | $3,113 | $72 |
| Diagnostic mammography of both breasts | 84 | $3,059 | $36 |
| Mri scan of both breasts | 31 | $2,812 | $91 |
| Ct scan of blood vessels of chest with contrast | 34 | $2,536 | $75 |
| Ct scan of chest with contrast | 43 | $1,969 | $45 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | 15 | $1,641 | $109 |
| Ct scan of upper spine without contrast | 39 | $1,525 | $39 |
| Placement of locating device in breast using imaging guidance, first growth | 17 | $1,430 | $84 |
| Ct scan of blood vessels of head with contrast | 18 | $1,301 | $72 |
| Ct scan of blood vessels of neck with contrast | 19 | $1,254 | $66 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 46 | $1,189 | $26 |
| Ct scan of chest without contrast | 23 | $969 | $42 |
| Mri scan of brain without contrast | 15 | $847 | $56 |
| Complete ultrasound scan behind abdominal cavity | 24 | $635 | $26 |
| Dxa bone density measurement of hip, pelvis, spine | 60 | $619 | $10 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 31 | $567 | $18 |
| X-ray of abdomen, 1 view | 43 | $352 | $7 |
| X-ray of chest, 2 views | 41 | $339 | $8 |
| Injection of radioactive material for x-ray identification of lymph node | 15 | $306 | $20 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 14 | $261 | $19 |
| X-ray of hip, 2-3 views | 25 | $209 | $8 |
| X-ray of shoulder, minimum of 2 views | 15 | $120 | $7 |
| X-ray of pelvis, 1-2 views | 15 | $111 | $7 |
| X-ray of thigh bone, minimum 2 views | 11 | $77 | $7 |
| X-ray of lower leg, 2 views | 11 | $68 | $6 |
2020: 35 services
| Screening mammography | 1,167 | $47,211 | $40 |
| Screening 3d breast mammography | 1,170 | $37,365 | $32 |
| Ct scan of abdomen and pelvis with contrast | 128 | $10,000 | $76 |
| X-ray of chest, 1 view | 686 | $5,874 | $7 |
| Diagnostic mammography of 1 breast | 122 | $4,485 | $31 |
| Ct scan head or brain without contrast | 119 | $4,281 | $34 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 32 | $4,247 | $133 |
| Limited ultrasound scan of 1 breast | 134 | $3,934 | $27 |
| Ct scan of abdomen and pelvis without contrast | 52 | $3,872 | $73 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 149 | $3,619 | $24 |
| Ct scan of chest with contrast | 68 | $3,401 | $49 |
| Mri scan of both breasts | 32 | $3,140 | $98 |
| Diagnostic mammography of both breasts | 81 | $3,082 | $38 |
| Ct scan of chest without contrast | 48 | $2,288 | $47 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | 16 | $2,040 | $128 |
| Ct scan of blood vessels of chest with contrast | 26 | $1,842 | $71 |
| Ct scan of upper spine without contrast | 42 | $1,721 | $41 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 30 | $1,426 | $48 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 44 | $1,251 | $28 |
| Ct scan of blood vessels of head with contrast | 16 | $1,193 | $75 |
| Complete ultrasound scan behind abdominal cavity | 33 | $1,004 | $30 |
| Ct scan of blood vessels of neck with contrast | 14 | $991 | $71 |
| Mri scan of brain without contrast | 17 | $929 | $55 |
| Low dose ct scan (ldct) for lung cancer screening | 14 | $762 | $54 |
| X-ray of chest, 2 views | 67 | $596 | $9 |
| Limited ultrasound scan of abdomen | 21 | $474 | $23 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 25 | $451 | $18 |
| Complete ultrasound scan of abdomen | 11 | $372 | $34 |
| X-ray of abdomen, 1 view | 45 | $367 | $7 |
| X-ray of hip, 2-3 views | 30 | $300 | $10 |
| Ultrasound scan of head and neck soft tissue | 12 | $264 | $22 |
| Injection of radioactive material for x-ray identification of lymph node | 11 | $243 | $22 |
| X-ray of pelvis, 1-2 views | 19 | $166 | $8 |
| X-ray of shoulder, minimum of 2 views | 14 | $114 | $8 |
| X-ray of lower leg, 2 views | 11 | $62 | $6 |
2019: 34 services
| Screening mammography | 1,177 | $46,848 | $40 |
| Screening 3d breast mammography | 1,176 | $37,115 | $32 |
| Ct scan of abdomen and pelvis with contrast | 158 | $11,664 | $74 |
| Ct scan head or brain without contrast | 192 | $6,704 | $34 |
| Ct scan of abdomen and pelvis without contrast | 65 | $4,850 | $73 |
| X-ray of chest, 1 view | 546 | $4,306 | $7 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 31 | $4,149 | $126 |
| Ct scan of chest with contrast | 78 | $3,828 | $49 |
| Limited ultrasound scan of 1 breast | 119 | $3,285 | $24 |
| Diagnostic mammography of 1 breast | 92 | $3,141 | $30 |
| Ct scan of chest without contrast | 65 | $3,122 | $47 |
| Mri scan of both breasts | 32 | $3,090 | $97 |
| Ct scan of blood vessels of chest with contrast | 41 | $3,057 | $75 |
| Diagnostic mammography of both breasts | 85 | $2,985 | $34 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 120 | $2,725 | $22 |
| Ct scan of upper spine without contrast | 61 | $2,656 | $44 |
| Placement of locating device in breast using imaging guidance, first growth | 20 | $1,706 | $85 |
| Ct scan of blood vessels of neck with contrast | 16 | $1,125 | $70 |
| Ct scan of blood vessels of head with contrast | 14 | $988 | $71 |
| X-ray of chest, 2 views | 120 | $921 | $8 |
| Mri scan of brain without contrast | 12 | $676 | $56 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 22 | $631 | $29 |
| Complete ultrasound scan behind abdominal cavity | 19 | $568 | $30 |
| Limited ultrasound scan of abdomen | 22 | $538 | $24 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 26 | $450 | $17 |
| X-ray of abdomen, 1 view | 56 | $417 | $7 |
| Ct scan of face without contrast | 11 | $381 | $35 |
| X-ray of hip, 2-3 views | 33 | $258 | $8 |
| X-ray of shoulder, minimum of 2 views | 27 | $217 | $7 |
| Injection of radioactive material for x-ray identification of lymph node | 13 | $195 | $15 |
| X-ray of lower and sacral spine, 2-3 views | 22 | $172 | $8 |
| X-ray of middle spine, 2 views | 16 | $134 | $8 |
| X-ray of chest, 2 views | 17 | $124 | $7 |
| X-ray of knee, 3 views | 11 | $83 | $7 |
2018: 31 services
| Screening mammography | 777 | $30,001 | $39 |
| Screening 3d breast mammography | 761 | $23,492 | $31 |
| Ct scan of abdomen and pelvis with contrast | 77 | $5,754 | $75 |
| Ct scan head or brain without contrast | 103 | $3,537 | $34 |
| X-ray of chest, 1 view | 359 | $2,992 | $7 |
| Diagnostic mammography of 1 breast | 77 | $2,921 | $33 |
| Limited ultrasound scan of 1 breast | 84 | $2,614 | $28 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 18 | $2,408 | $134 |
| Ct scan of abdomen and pelvis without contrast | 34 | $2,404 | $71 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 92 | $2,272 | $24 |
| Diagnostic mammography of both breasts | 53 | $2,154 | $41 |
| Ct scan of blood vessels of chest with contrast | 25 | $1,871 | $75 |
| Ct scan of chest with contrast | 35 | $1,722 | $49 |
| X-ray of chest, 2 views | 188 | $1,607 | $8 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | 11 | $1,584 | $132 |
| MRI scan of both breasts with contrast | 20 | $1,343 | $67 |
| Placement of locating device in breast using imaging guidance, first growth | 15 | $1,252 | $83 |
| Ct scan of upper spine without contrast | 20 | $866 | $43 |
| Ct scan of chest without contrast | 11 | $526 | $48 |
| Complete ultrasound scan behind abdominal cavity | 12 | $366 | $30 |
| X-ray of hip, 2-3 views | 36 | $330 | $9 |
| X-ray of abdomen, 1 view | 35 | $326 | $8 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 16 | $293 | $18 |
| X-ray of shoulder, minimum of 2 views | 32 | $264 | $7 |
| X-ray of pelvis, 1-2 views | 22 | $156 | $7 |
| X-ray of chest, 2 views | 13 | $117 | $9 |
| X-ray of lower and sacral spine, 2-3 views | 13 | $106 | $8 |
| X-ray of thigh bone, minimum 2 views | 11 | $89 | $8 |
| X-ray of knee, 1-2 views | 14 | $87 | $6 |
| X-ray of foot, minimum of 3 views | 11 | $85 | $7 |
| X-ray of lower leg, 2 views | 13 | $85 | $7 |
2017: 2 services
| X-ray of chest, 1 view, front | 34 | $272 | $8 |
| X-ray of abdomen, single view | 15 | $140 | $8 |
Medicaid work
$7,877 in 2024
Medicaid paid $7,877 for 351 billed services this clinician did in 2024, up to 27 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed | 172 | $4,193 |
| SCREENING DIGITAL BREAST TOMOSYNTHESIS BI | 165 | $3,004 |
| Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited | 14 | $680 |
| 2024 | 351 | 3 | 27 | $7,877 |
| 2023 | 357 | 3 | 35 | $7,021 |
| 2022 | 1,286 | 7 | 125 | $26,946 |
| 2021 | 1,326 | 5 | 79 | $28,022 |
| 2020 | 1,137 | 7 | 83 | $21,067 |
| 2019 | 1,110 | 8 | 61 | $30,867 |
| 2018 | 934 | 7 | 75 | $16,753 |
See the largest Medicaid services in earlier years
2023
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed | 170 | $3,643 |
| SCREENING DIGITAL BREAST TOMOSYNTHESIS BI | 163 | $2,891 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 24 | $486 |
2022
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed | 272 | $10,073 |
| SCREENING DIGITAL BREAST TOMOSYNTHESIS BI | 270 | $8,200 |
| Radiologic examination, chest; single view | 601 | $4,374 |
| Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited | 55 | $2,067 |
| CT ABDOMEN & PELVIS W/O CONTRAST MATERIAL | 20 | $1,205 |
| Computed tomography, head or brain; without contrast material | 20 | $563 |
| Radiologic examination, chest; 2 views | 48 | $465 |
2021
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed | 292 | $11,246 |
| SCREENING DIGITAL BREAST TOMOSYNTHESIS BI | 290 | $9,027 |
| Radiologic examination, chest; single view | 685 | $4,636 |
| CT ABDOMEN & PELVIS W/CONTRAST MATERIAL | 29 | $2,190 |
| Computed tomography, head or brain; without contrast material | 30 | $923 |
2020
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed | 131 | $5,122 |
| CT ABDOMEN & PELVIS W/CONTRAST MATERIAL | 79 | $4,889 |
| Radiologic examination, chest; single view | 725 | $4,751 |
| SCREENING DIGITAL BREAST TOMOSYNTHESIS BI | 131 | $4,109 |
| Computed tomography, head or brain; without contrast material | 46 | $1,346 |
| VASCULAR STUDY | 12 | $740 |
| Radiologic examination, chest; 2 views | 13 | $109 |
2019
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed | 240 | $9,276 |
| SCREENING DIGITAL BREAST TOMOSYNTHESIS BI | 242 | $7,356 |
| CT ABDOMEN & PELVIS W/CONTRAST MATERIAL | 90 | $6,973 |
| Radiologic examination, chest; single view | 367 | $3,078 |
| Computed tomography, head or brain; without contrast material | 84 | $2,291 |
| DIAGNOSTIC COMPUTED TOMOGRAPHY THORAX W/CONTRAST | 18 | $828 |
| Radiologic examination, chest; 2 views | 57 | $612 |
| Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited | 12 | $453 |
2018
| CT ABDOMEN & PELVIS W/CONTRAST MATERIAL | 51 | $4,090 |
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed | 100 | $3,900 |
| SCREENING DIGITAL BREAST TOMOSYNTHESIS BI | 98 | $3,016 |
| Radiologic examination, chest; single view | 435 | $2,459 |
| Computed tomography, head or brain; without contrast material | 65 | $1,782 |
| Radiologic examination, chest; 2 views | 173 | $1,017 |
| Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited | 12 | $489 |
Money from drug and device companies
$305 in 2022
| 2022 | 13 | 21 | None | $305 |
| 2021 | 15 | 25 | None | $536 |
| 2020 | 10 | 14 | None | $272 |
| 2019 | 8 | 10 | None | $207 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Lumakras | $44 | 2 payments
|
| Seagen | Tukysa | $28 | 1 payment
|
| GlaxoSmithKline | Blenrep | $26 | 1 payment
|
| Regeneron Healthcare Solutions | Libtayo | $25 | 1 payment
|
| MorphoSys US | Monjuvi | $25 | 1 payment
|
| Exelixis | Cabometyx | $23 | 1 payment
|
See all 14 published payments
| Hologic | Meals · 2022-11-11 | Aixplorer Ultimate | $16 |
| Exelixis | Meals · 2022-11-09 | Cabometyx | $23 |
| Amgen | Meals · 2022-11-01 | Lumakras | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2022-10-11 | Lynparza | $22 |
| Regeneron Healthcare Solutions | Meals · 2022-09-20 | Libtayo | $25 |
| Janssen Biotech | Meals · 2022-09-13 | Erleada | $19 |
| Incyte | Meals · 2022-08-23 | Jakafi | $20 |
| Celgene | Meals · 2022-05-10 | Pomalyst | $18 |
| Seagen | Meals · 2022-03-15 | Tukysa | $28 |
| MorphoSys US | Meals · 2022-03-08 | Monjuvi | $25 |
| GlaxoSmithKline | Meals · 2022-03-01 | Blenrep | $26 |
| Novartis Pharmaceuticals | Meals · 2022-02-15 | None | $20 |
| BeiGene USA | Meals · 2022-02-08 | Brukinsa | $19 |
| Amgen | Meals · 2022-01-18 | Lumakras | $17 |
See earlier years (2021, 2020, 2019)
2021: $536
| Amgen | Lumakras | $97 | 5 payments
|
| Seagen | Tukysa | $76 | 3 payments
|
| Merck Sharp & Dohme | Keytruda | $56 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Alunbrig | $43 | 2 payments
|
| Incyte | Monjuvi | $38 | 2 payments
|
| GlaxoSmithKline | Zejula | $32 | 1 payment
|
| Gilead Sciences | Trodelvy | $25 | 1 payment
|
| Janssen Biotech | Erleada | $25 | 1 payment
|
| Alexion Pharmaceuticals | Ultomiris | $25 | 1 payment
|
| Eisai | Halaven | $23 | 1 payment
|
| Genzyme | Jevtana | $22 | 1 payment
|
| BeiGene USA | Brukinsa | $20 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $20 | 1 payment
|
| Jazz Pharmaceuticals | Zepzelca | $18 | 1 payment
|
| Lilly USA | Verzenio | $16 | 1 payment
|
2020: $272
| Merck Sharp & Dohme | Keytruda | $70 | 4 payments
|
| Foundation Medicine | Foundationone | $34 | 1 payment
|
| Incyte | Pemazyre | $33 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $24 | 1 payment
|
| Agios Pharmaceuticals | Tibsovo | $23 | 1 payment
|
| Exelixis | Cabometyx | $19 | 1 payment
|
| Taiho Oncology | None | $19 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | None | $18 | 1 payment
|
| Jazz Pharmaceuticals | Zepzelca | $17 | 1 payment
|
| Daiichi Sankyo | Enhertu | $16 | 1 payment
|
2019: $207
| Amgen | Neulasta | $50 | 2 payments
|
| Lilly USA | Verzenio | $34 | 2 payments
|
| AbbVie | Venclexta | $25 | 1 payment
|
| Rigel Pharmaceuticals | Tavalisse | $24 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | None | $23 | 1 payment
|
| Janssen Biotech | Imbruvica | $19 | 1 payment
|
| Novartis Pharmaceuticals | Kisqali | $16 | 1 payment
|
| Hologic | Clarity | $14 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1467719294
- Licence
- CA A148784California A148784: Current · expires 2028-08-31
- Trained
- Albert Einstein College of Medicine of Yeshiva University, 2012
- Group
- Stanford Health Care
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Diagnostic radiology (2085R0202X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2012-04-18
- NPI last updated
- 2024-04-09
- NPI record certified
- 2024-04-09
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 121 Sotoyome St, Santa Rosa, CA, 95405